featured
Risk Factors for Macular Atrophy in Anti-VEGF Treatment for Age-Related Macular Degeneration
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Retina (Philadelphia, Pa.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Macular Atrophy Incidence in Anti-Vascular Endothelial Growth Factor-Treated Neovascular Age-Related Macular Degeneration: Risk Factor Evaluation for Individualized Treatment Need of Ranibizumab or Aflibercept According to an Observe-and-Plan Regimen
Retina (Philadelphia, Pa.) 2018 Jan 23;[EPub Ahead of Print], I Mantel, A Dirani, M Zola, P Parvin, S De Massougnes, C BerginFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.